---
title: "Longtech released its performance for the first three quarters, with a net profit attributable to the parent company of 86.3697 million yuan, a decrease of 17.05%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262447817.md"
description: "Longtech released its third-quarter report for 2025, with operating revenue for the first three quarters amounting to 1.225 billion yuan, a year-on-year increase of 0.11%. The net profit attributable to shareholders of the listed company was 86.3697 million yuan, a year-on-year decrease of 17.05%; the net profit after deducting non-recurring gains and losses was 75.5814 million yuan, a year-on-year decrease of 20.22%. The basic earnings per share were 0.6 yuan"
datetime: "2025-10-23T13:07:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262447817.md)
  - [en](https://longbridge.com/en/news/262447817.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262447817.md)
generator: "portal-rs"
---

# Longtech released its performance for the first three quarters, with a net profit attributable to the parent company of 86.3697 million yuan, a decrease of 17.05%

According to the Zhitong Finance APP, Longtech (300916.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 1.225 billion yuan, a year-on-year increase of 0.11%. The net profit attributable to shareholders of the listed company was 86.3697 million yuan, a year-on-year decrease of 17.05%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 75.5814 million yuan, a year-on-year decrease of 20.22%. The basic earnings per share were 0.6 yuan

### Related Stocks

- [300916.CN](https://longbridge.com/en/quote/300916.CN.md)

## Related News & Research

- [02:36 ETChina's BCI Race Accelerates: Gestala Raises US$84 Million in Six Months](https://longbridge.com/en/news/296996494.md)
- [Canada minister says he welcomes US clarification on French language requirements](https://longbridge.com/en/news/297196718.md)
- [Heidelberg Pharma says China NMPA clears HDP-101 combo trial in multiple myeloma](https://longbridge.com/en/news/297070749.md)
- [13:00 ETAPS Expands UPI High Output Alternator Line for Growing Power Needs in Luxury Motorcoaches](https://longbridge.com/en/news/297215641.md)
- [Lenzing shareholders approve EUR 300 million capital increase at extraordinary meeting](https://longbridge.com/en/news/296902548.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**